SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-20-000957
Filing Date
2020-03-31
Accepted
2020-03-31 18:30:09
Documents
1
Period of Report
2020-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form305735001_03312020.html 3  
1 OWNERSHIP DOCUMENT form305735001_03312020.xml 3 2818
  Complete submission text file 0000921895-20-000957.txt   4865
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 600 FIFTH AVENUE, 2ND FLOOR NEW YORK NY 10020
Business Address 600 FIFTH AVENUE, 2ND FLOOR NEW YORK NY 10020 801-214-7800
Myrexis, Inc. (Reporting) CIK: 0001459450 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-36435 | Film No.: 20763216
SIC: 2834 Pharmaceutical Preparations